Vaxcyte Posts $1.99 Q3 GAAP Loss Per Share, 15 Cents Better Than Estimate

Cash, cash equivalents and investments totaled $2,264.4 million on Sept. 30, down from $2,442.6 million at year-end 2025.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.